Deadline: February 15, 2023

The TERMIS-AM 2023 Conference will feature an outstanding scientific program bringing together national and international communities of scientists, clinicians, industry leaders, post-doctoral fellows, graduate students, entrepreneurs, and representatives of government funding agencies engaged in the fields of tissue engineering and regenerative medicine.

Abstract Consideration
Experts from academia, industry and government are invited to present timely research to successful implementation of technologies in all areas of tissue engineering/regenerative medicine.

Note: All abstract submitters including presenting authors are expected to pay their own travel expenses and conference registration fee(s).


The below timeline has been put in place for submission, review, and status notifications.

January 2023
    • Late breaking abstracts opens January 30, 2023.
February 2023
    • Late breaking abstracts closes February 15, 2023.
    • Abstract status notifications will be sent by March 1.


You will be able to select the general TWIG category or the specific subcategory beneath each.

Biofabrication & Bioreactors – TWIG

  • Complex Organ Decellularization: How Close Are We to Translation?
  • Micro/nano Biofabrication of Organ-on-chips, Organoids and Disease Models
  • Multi-dimensional Bioprinting and Novel Tissue Patterning Techniques
  • Organoids and Microphysiological Systems
  • Organ-on-chip/Bioreactor

Cardiovascular/Angiogenesis/Blood – TWIG

  • Building Networks: Advances in Tissue and Organ Vascularization
  • Cardiovascular Devices

Commercialization & Regulation – TWIG

Dental & Craniofacial – TWIG

Imaging and Assessment – TWIG

  • Noninvasive Imaging and Assessment Tools for Evaluating Biomaterials and Engineered Tissues

Musculoskeletal – TWIG

  • Articular Cartilage Tissue Engineering & Translation
  • Interoception Mediated Musculoskeletal Tissue Regeneration
  • Muscle Biology and Aging

Neural & Spine – TWIG

  • Strategies for Regeneration of the Nervous System

Ophthalmologic – TWIG

  • Tissue Engineered Ocular Tissues For Disease Modeling and Cell Therapies

Respiratory, Urologic & Gastrointestinal – TWIG

  • Engineering and Regeneration of Airway, Digestive, or Urogenital Systems

Scaffolds, Matrices, and Biomaterials – TWIG

  • ASMB Symposium: Engineering the Matrix for Healing
  • Biomimetic and Unconventional Biomaterials and Scaffolds for Tissue Repair and Regeneration
  • Emerging Technology Highlights – Melt Electrowriting and Extracellular Vesicles
  • MXenes: The Next Generation Nanomaterials for Regenerative Medicine and Immunoengineering
  • Unconventional Biomaterials for Tissue Engineering and Regenerative Medicine

Skin, Wound Healing, and Inflammation – TWIG

  • Extracellular Vesicles as Therapies in Regenerative Medicine

Stem Cells & Cell Therapies & Developmental Biology and Cell Signaling – TWIG

  • Measuring and Modelling Tissue Aging, Rejuvenation and Regeneration
  • Stem Cells & Cell Therapies & Developmental Biology and Cell Signaling


  • Bioengineered in Vitro Cancer Models: Modeling the Complexity of Cancer in Tumor Organoids, Tumor Constructs, and Tumor-on-a-chip Technologies
  • Regenerative Rehabilitation – Functional Translation of Biologically Inspired Regenerative Technologies
  • Tissue Engineering Strategies for Pediatric Diseases and Disorders


Abstract Preparation
Authors must submit their abstract electronically. This is the ONLY option for abstract submission.

Title: Title should be brief, clearly indicating the nature of the presentation. Title should be in bold font and mixed case font followed by a single return. Do not put a period at the end of the title. 
Example: This is a Properly Formatted Abstract Title

Category: Please select the TWIG category that your abstract falls under. You can select your primary, secondary, and tertiary preference for categories, but only one is required.

Authors: This is where you will enter your authors and it will be separate from your abstract body. Please enter information in the fields provided and the system with format it for you automatically. Complete contact information (name, mailing address, and e-mail) for each author listed on the abstract must be entered before submitting the abstract file.

Disclosure InformationSubmitting disclosures is a step when entering abstract authors. It will be the same step under each individual speaker. In order for your colleagues to properly evaluate the information, analysis and opinions presented in your abstract, it is important that they be informed of potential conflicts of interest pertinent to the research submitted. Therefore, conference management requires that all authors provide any relevant information concerning personal or professional circumstances and relationships that might reasonably be expected to affect the author’s view on the subject. Examples include, but are not limited to:

  • Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  • Employment (full or part-time)
  • Ownership or partnership
  • Consulting fees or other remuneration (payment)
  • Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson
  • Receipt of royalties
  • Speakers bureau

Appropriate disclosure will be stated in the scientific program and the abstract volume. If you do not have anything to disclose, you must indicate this on the online abstract submission form. The disclosure information you provide will not influence the review of your abstract. Abstracts will not be reviewed without proper completion of the disclosure section on the abstract submission form. Disclosure information for all authors is required upon abstract submission.

Keyword(s): Please enter a minimum of one keyword and a maximum of 5 keywords.

Abstract: The abstract should clearly describe the nature of the research and the problem it addresses and be presented in such language as to be understood by scientists representing the multi-disciplinary nature of tissue engineering. The abstract should summarize the purpose/objective of the research, the methodology employed, the results, and the conclusion/significance and will be split into these four categories.

  • The abstract length is limited to 250 words total across all four sections. These areas should not include authors, disclosures, or references.
  • Please no figures or tables in the abstract.
  • References and acknowledgements are not needed in this abstract process.

Demographics: You can select if you are a Student or Young Investigator here. Please fill out the other demographic information if you feel comfortable. These questions help us promote diversity within our abstract presenters.

You will then have an opportunity to review and edit your work before submitting the abstract.

Submission: The final step before submitting your abstract will allow you the opportunity to review and edit your work and make any needed edits. Once an abstract is submitted no further edits can be made.

Abstract Withdrawals

If the abstract must be withdrawn, the TERMIS-AM office must be notified in writing at least ONE month prior to the meeting via e-mail to


Registration Requirements

Accepted authors are expected to pay their own travel expenses and conference registration fee(s). Dates of presentation cannot be guaranteed.

If an abstract has been accepted as a five-minute rapid fire presentation, a poster presentation will also be required.

For More Information

For more information on abstract content, format and submission procedure, contact:

Tatiana Veres & Jill Steckler
Associate Meeting Managers